Travere Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Travere Therapeutics Inc
CIK #0001438533
EDGAR Form CIK 2011 - 2026
10-K [0001438533]
10-Q [0001438533]
3 [0001438533]
4 [0001438533]
5 [0001438533]
8-K [0001438533]
D [0001438533]
SC 13D [0001438533]
SC 13G [0001438533]
Form 13D/13G Filer Form 13D/13G Subject Filed
Armistice Capital LLC Travere Therapeutics Inc [2026-05-15]
Vanguard Capital Management LLC Travere Therapeutics Inc [2026-04-30]
State Street Corp Travere Therapeutics Inc [2026-02-09]
FMR LLC Travere Therapeutics Inc [2026-01-08]
Perceptive Advisors LLC Travere Therapeutics Inc [2025-10-14]
Janus Henderson Group PLC Travere Therapeutics Inc [2025-05-14]
Woodline Partners LP Travere Therapeutics Inc [2024-11-14]
Rock Springs Capital Management LP Travere Therapeutics Inc [2024-05-01]
Morgan Stanley Travere Therapeutics Inc [2024-02-09]
Adage Capital Partners GP LLC Travere Therapeutics Inc [2023-03-13]
State Street Corp Travere Therapeutics Inc [2023-02-06]
Adage Capital Partners GP LLC Travere Therapeutics Inc [2022-10-28]
Deep Track Capital LP Travere Therapeutics Inc [2022-05-16]
Armistice Capital LLC Travere Therapeutics Inc [2022-02-14]
Goldman Sachs Group Inc Travere Therapeutics Inc [2022-02-01]
Deep Track Capital LP Travere Therapeutics Inc [2021-08-13]
Janus Henderson Group PLC Travere Therapeutics Inc [2021-02-12]
Macquarie Group Ltd Travere Therapeutics Inc [2021-02-12]
Adage Capital Partners GP LLC Travere Therapeutics Inc [2021-01-04]
RA Capital Management LP Retrophin Inc [2020-02-14]
Manulife Financial Corp Retrophin Inc [2020-02-12]
Vanguard Group Inc Retrophin Inc [2020-02-11]
Integrated Core Strategies US LLC Retrophin Inc [2020-01-28]
Broadfin Capital LLC Retrophin Inc [2019-07-19]
Macquarie Group Ltd Retrophin Inc [2019-02-14]
Perceptive Advisors LLC Retrophin Inc [2019-02-14]
Scopia Capital Management LP Retrophin Inc [2016-03-31]
Goldman Sachs Group Inc Retrophin Inc [2016-02-09]
BlackRock Inc Retrophin Inc [2016-01-28]
Consonance Capital Management LP Retrophin Inc [2015-02-17]
Lombard Odier Asset Management USA Corp Retrophin Inc [2015-02-11]
Jennison Associates LLC Retrophin Inc [2014-02-10]
Prudential Financial Inc Retrophin Inc [2014-02-05]
SAC Capital Advisors LP Retrophin Inc [2014-01-17]
Broadfin Capital LLC Retrophin Inc [2014-01-17]
RRC Management LLC Retrophin Inc [2014-01-02]
QVT Financial LP Retrophin Inc [2013-08-26]
RRC Management LLC Retrophin Inc [2013-02-25]
Sabby Management LLC Desert Gateway Inc [2013-02-15]
Ligand Pharmaceuticals Inc Desert Gateway Inc [2013-01-11]
[2012-12-20]
Form 3/4/5 Subject 2011 - 2026
Inrig Jula
Travere Therapeutics Inc
Coughlin Timothy
Baynes Roy D
Meckler Jeffrey A
Williams Brinkley Ruth
Lyons Gary A
Squarer Ron
Poole Sandra
Bruhn Suzanne Louise
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Travere Therapeutics Inc TVTX
Common Stock
2026-03-16 Sell 10,000 $28.09 280,900
Travere Therapeutics Inc TVTX
Employee stock option (right to buy) · derivative
2026-03-16 Option exercise 10,000 $0.00
Travere Therapeutics Inc TVTX
Common Stock
2026-03-16 Option exercise 10,000 $19.08 190,800
Travere Therapeutics Inc TVTX
Common Stock
2026-02-20 Sell 60,000 $30.10 1,806,000
Travere Therapeutics Inc TVTX
Common Stock
2026-02-20 Option exercise 60,000 $15.46 927,600
Travere Therapeutics Inc TVTX
Employee stock option (right to buy) · derivative
2026-02-20 Option exercise 60,000 $0.00
Travere Therapeutics Inc TVTX
Common Stock
2026-02-17 Sell 4,321 $28.26 122,111
Travere Therapeutics Inc TVTX
Employee stock option (right to buy) · derivative
2026-02-17 Option exercise 10,000 $0.00
Travere Therapeutics Inc TVTX
Common Stock
2026-02-17 Sell 5,679 $27.50 156,172
Travere Therapeutics Inc TVTX
Common Stock
2026-02-17 Option exercise 10,000 $19.08 190,800
Travere Therapeutics Inc TVTX
Common Stock
2026-02-04 Sell 1,547 $32.11 49,674
Travere Therapeutics Inc TVTX
Common Stock
2026-02-04 Sell 1,635 $32.14 52,549
Travere Therapeutics Inc TVTX
Common Stock
2026-02-04 Sell 509 $32.74 16,665
Travere Therapeutics Inc TVTX
Common Stock
2026-02-04 Sell 110 $32.90 3,619
Travere Therapeutics Inc TVTX
Common Stock
2026-02-04 Sell 232 $32.85 7,621
Travere Therapeutics Inc TVTX
Common Stock
2026-02-04 Sell 2,485 $32.07 79,694
Travere Therapeutics Inc TVTX
Common Stock
2026-02-03 Sell 7,242 $32.12 232,613
Travere Therapeutics Inc TVTX
Common Stock
2026-02-03 Sell 7,175 $32.12 230,461
Travere Therapeutics Inc TVTX
Common Stock
2026-02-03 Sell 12,446 $32.87 409,100
Travere Therapeutics Inc TVTX
Common Stock
2026-02-03 Sell 7,310 $32.12 234,797
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com